SCHEMBL31192065

SCHEMBL31192065

Brc1ccc(-c2nc(-c3ccccc3)c3sc4ccccc4c3n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1B1 Q16678 4/20 0.43
▸ CYP1A2 P05177 3/20 0.43
▸ CYP1A1 P04798 2/20 0.43
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ ABCG2 Q9UNQ0 2/20 0.40
▸ NR1H4 Q96RI1 1/20 0.40
▸ TNKS O95271 2/20 0.39
▸ TNKS2 Q9H2K2 2/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ DGAT1 O75907 1/20 0.38
▸ NR1H2 P55055 1/20 0.38
▸ NR1H3 Q13133 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23327832 1.00 CYP1B1 (0.43) CYP1B1CYP1A2CYP1A1MEN1KMT2A
SCHEMBL20068415 1.00 CYP1B1 (0.43) CYP1B1CYP1A2CYP1A1MEN1KMT2A
SCHEMBL17548887 0.99 CYP1B1 (0.42) CYP1B1CYP1A2CYP1A1MEN1KMT2A
SCHEMBL18017854 0.93 MEN1 (0.45) CYP1A2MEN1KMT2AATMTNKS
SCHEMBL18017759 0.93 MEN1 (0.45) CYP1A2MEN1KMT2AATMTNKS
SCHEMBL18017848 0.93 MEN1 (0.45) CYP1A2MEN1KMT2AATMTNKS
SCHEMBL16902239 0.92 MEN1 (0.44) CYP1A2MEN1KMT2AATMTNKS
SCHEMBL18017762 0.92 MEN1 (0.44) CYP1A2MEN1KMT2AATMTNKS
SCHEMBL18017908 0.92 MEN1 (0.44) CYP1A2MEN1KMT2AATMTNKS
SCHEMBL18017773 0.92 MEN1 (0.44) CYP1A2MEN1KMT2AATMTNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12415949-B2 Compound, organic electroluminescent device, and display device SK INC. (KR) 2025-09-16 — — US disclosed
CN-118922414-A Organic compound and organic electroluminescent element using same 索路思高新材料有限公司 2024-11-08 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415949-B2 Compound, organic electroluminescent device, and display device L1CAM, EML4, OCIAD2 CYP1B1 2469/4885CYP1A2 1436/4885CYP1A1 1760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback